Cargando…

Environmental risk factors and comorbidities of primary biliary cholangitis in Korea: a case-control study

BACKGROUND/AIMS: The risk factors for the development of primary biliary cholangitis (PBC) is unclear. This study aimed to investigate the risk factors associated with PBC in Korea through a questionnaire survey. METHODS: Consecutively enrolled 103 PBC patients from six referral hospitals and 100 ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kyung-Ah, Kim, Young Seok, Park, Sang Hoon, Chung, Woo Jin, Choi, Dae Hee, Jang, Eun Sun, Jeong, Sook-Hyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969053/ https://www.ncbi.nlm.nih.gov/pubmed/32204000 http://dx.doi.org/10.3904/kjim.2019.234

Ejemplares similares

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

The diagnosis and treatment of primary biliary cirrhosis
por: Kim, Kyung-Ah, et al.
Publicado: (2011)

Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era
por: Jang, Eun Sun, et al.
Publicado: (2017)

Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
por: Jang, Eun Sun, et al.
Publicado: (2020)

Current status of hepatitis C virus infection and countermeasures in South Korea
por: Jeong, Sook-Hyang, et al.
Publicado: (2017)

Geographic differences in the epidemiological features of HCV infection in Korea
por: Kim, Kyung-Ah, et al.
Publicado: (2014)

Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
por: Kim, Kyung-Ah, et al.
Publicado: (2023)

Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio
por: Yoo, Jeong-Ju, et al.
Publicado: (2018)

Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]
por: Kim, Kyung-Ah, et al.
Publicado: (2023)

Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis
por: Lee, Hee Seung, et al.
Publicado: (2018)

Evidence from a familial case suggests maternal inheritance of primary biliary cholangitis
por: Shin, Saeam, et al.
Publicado: (2017)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea
por: Kim, Bo Hyun, et al.
Publicado: (2017)

Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis
por: Dyson, Jessica Katharine, et al.
Publicado: (2020)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data
por: Ki, Moran, et al.
Publicado: (2017)

Etiology and clinical characteristics of acute viral hepatitis in South Korea during 2020–2021: a prospective multicenter study
por: Jeong, Chan Young, et al.
Publicado: (2023)

Home intravenous antibiotic treatment for intractable cholangitis in patients with biliary atresia following Kasai portoenterostomies
por: Shin, Jae Ho, et al.
Publicado: (2011)

Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D
por: Jang, Eun Sun, et al.
Publicado: (2018)

Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
por: Jang, Eun Sun, et al.
Publicado: (2021)

Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice
por: Kim, Kyung-Hyun, et al.
Publicado: (2015)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

The More, the Better? Predicting Prognosis in Primary Biliary Cholangitis
por: Kim, Bo Hyun
Publicado: (2018)

Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis
por: Probert, Philip M., et al.
Publicado: (2018)

A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
por: Kim, Hye-Lin, et al.
Publicado: (2022)

A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale
por: Levy, Cynthia, et al.
Publicado: (2018)

Association between Skin Cancer and Systemic and Ocular Comorbidities in South Korea
por: Lee, Sul Hee, et al.
Publicado: (2021)

Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009
por: Kim, Kyung-Ah, et al.
Publicado: (2017)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Timing of biliary decompression for acute cholangitis
por: Yang, Jian, et al.
Publicado: (2023)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey
por: Park, Hee Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cse1pmjbghid3nk6l24ue2vlea